Med Page Today
MARCH 8, 2024
(MedPage Today) -- The FDA approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight, the agency announced on Friday. A GLP-1 receptor.
HCPLive
MARCH 7, 2024
On March 07, 2024, Boehringer Ingelheim announced it would be instituting a $35 per month out-of-pocket cost cap for its portfolio of inhaler products, with this cap going into effect on June 01, 2024.
American Heart News - Heart News
MARCH 5, 2024
Research Highlights: An analysis of health data in the UK Biobank found a 20% higher risk of irregular heart rhythm, known as atrial fibrillation, among people who said they drank two liters or more per week (about 67 ounces) of artificially sweetened.
DAIC
MARCH 6, 2024
Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Data from a preliminary analysis of Bodyport’s SCALE-HF 1 study were presented on the final day of the Cardiovascular Research Foundation’s third annual Technology and Heart Failure Therapeutics (THT) conference being held in
Med Page Today
MARCH 6, 2024
(MedPage Today) -- It was common for tiny plastic particles from the environment to infiltrate people's vascular lesions, foreshadowing future cardiovascular disease in patients who underwent carotid endarterectomy, an observational study showed.
HCPLive
MARCH 8, 2024
On March 08, 2024, the FDA approved semaglutide 2.4 mg (Wegovy) to reduce cardiovascular risk in adults with obesity or overweight and heart disease based on the SELECT trial.
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Med Page Today
MARCH 4, 2024
(MedPage Today) -- The FDA said that it will not object to the use of a qualified health claim that eating yogurt is associated with a reduced risk of type 2 diabetes, the agency announced Friday. After a review of the evidence -- albeit limited.
HCPLive
MARCH 8, 2024
A new analysis of the phase 3 ADORING 3 extension trial involved a large, diverse population and the analysis showed that 91% of eligible participants from previous phases rolled over into this trial.
CardiacWire
MARCH 8, 2024
A landmark NEJM study revealed that many patients with carotid artery disease might have microplastics and nanoplastics (MNPs) embedded in their carotid plaque, and those patients have a massive 4.5-fold greater risk of heart attack, stroke, or death within three years. The researchers examined carotid plaque specimens from 257 patients with asymptomatic carotid artery disease, analyzing their plaque for the presence of 11 MNPs, and tracking the patients’ cardiovascular outcomes over 34 months.
Becker's Hospital Review - Cardiology
MARCH 7, 2024
We all have microplastics in our bodies , but if they show up in carotid artery tissues, patients are nearly two times as likely to experience a stroke, heart attack or related death, according to a study published March 7 in The New England Journal of Medicine.
Med Page Today
MARCH 5, 2024
(MedPage Today) -- Overconsumption of beverages with added sugar or artificial sweetener, already associated with several cardiometabolic diseases, showed new links to atrial fibrillation (Afib or AF) in a prospective cohort study. Within the.
Dr. Smith's ECG Blog
MARCH 7, 2024
A young man presented with a gunshot wound to the right chest, with hemo-pneumothorax and hemorrhagic shock. He got a chest tube and intubation and massive transfusion and stabilized. CT of chest showed the bullet path through his right lung but nowhere near his heart. But he did get an EKG: What is this? There were times when it would be usurped by sinus tachycardia, then return to this rhythm.
Cardiology Update
MARCH 5, 2024
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. The study evaluated outcomes associated with an invasive strategy involving angiography and percutaneous coronary intervention (PCI) or surgical coronary artery bypass grafting (CABG), compared to a conservative strategy involving initial medical therapy.
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives. ML algorithms can potentially analyze complex patterns and correlations within medical data, enabling early detection and accurate diagnosis of CAD.
DAIC
MARCH 5, 2024
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10. 1. Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society 2. ISC 2024 Late-breaking Science Finding from ZODIAC Study: Position of Head Before Surgery May Improve Stroke Patient’s Neurological Function 3.
Dr. Smith's ECG Blog
MARCH 4, 2024
I have often written about how an ECG interpreted as "normal" by a conventional algorithm may well be manifesting OMI, or even long QT or hyperkalemia. I have collected 51 OMI cases that were diagnosed as completely normal by the conventional automated computer algorithm. Shifa Karim and Gabe Keller helped with a project to assess all these ECGs with the Queen of Hearts.
HCPLive
MARCH 4, 2024
The overall effect of psychological interventions on patients with fibromyalgia was -0.31 for depressive symptoms and -0.15 for anxiety symptoms, which were deemed statistically significant.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Background Previous studies have shown that global constructive work (CW) and wasted work (WW) predict response to cardiac resynchronization therapy (CRT). This study evaluated the predictive value of regional CW and WW for reverse remodeling and clinical outcomes after CRT. Methods We performed a prospective study involving 134 CRT candidates with left bundle branch block and left ventricular ejection fraction ≤35%.
Cardiology Update
MARCH 4, 2024
The optimal surveillance strategy after percutaneous coronary intervention (PCI) for high-risk patients with multivessel or left main coronary artery disease (CAD) remains uncertain. In the the POST-PCI (Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention; NCT03217877 ) trial, recently published in JACC, investigators aimed to determine prognostic role of routine functional testing in patients with multivess
DAIC
MARCH 7, 2024
Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion, and expected to reach $3.18 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence.
Med Page Today
MARCH 6, 2024
(MedPage Today) -- The first over-the-counter continuous glucose monitor (CGM) was cleared for use by adults with or without diabetes, the FDA announced on Tuesday. The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) that will.
HCPLive
MARCH 5, 2024
The FDA has greenlit Dexcom's Stelo Glucose Biosensor System, marking a historic first as the first continuous glucose monitors to be available over-the-counter.
Becker's Hospital Review - Cardiology
MARCH 4, 2024
"Discover the incredible story of Bert Janssen, the Dutch man who has lived with a donor heart for 39 years and 252 days, officially confirmed as the world's lo
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
Background Cardiac autonomic function (CAF) decreases with aging, and Acanthopanax senticosus Harms (ASH) consumption reportedly induces anti-stress effects. This study aimed to assess the effect of continuous supplementation of ASH on CAF during resting and standing tests in the elderly population. Methods This double-blind, randomized controlled trial was conducted in the morning in a laboratory setting and was carried out between June 2017 and July 2017 at Kambaikan, Doshisha University (Kara
Med Page Today
MARCH 7, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Accruing about 10,000 steps per day was associated with the lowest mortality risk independent of sedentary time, but any amount above 2,200 steps a day showed mortality.
DAIC
MARCH 7, 2024
milla1cf Thu, 03/07/2024 - 20:01 March 7, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular disorders, today announced positive interim results from the Phase III randomized controlled trial of its CardiAMP autologous cell therapy in 110 randomized patients with advanced chronic heart failure at a mean 20-month follow-up, ( CardiAMP HF ).
HCPLive
MARCH 8, 2024
In phase 4 data from the IMMpulse study, presented at AAD 2024, comparisons in efficacy were highlighted between risankizumab and apremilast for psoriasis patients eligible for systemic therapy.
Science Daily - Heart Disease
MARCH 6, 2024
More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovascular disease, a new study suggests. In some cases, these levels -- specifically high low-density lipoprotein (LDL) cholesterol, often thought of as 'bad cholesterol,' -- were linked to plaque buildup and cardiovascular events, such as heart attack and stroke.
Med Page Today
MARCH 8, 2024
(MedPage Today) -- In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and proliferative diabetic retinopathy.
DAIC
MARCH 7, 2024
milla1cf Thu, 03/07/2024 - 20:23 March 7, 2024 — Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as surgeons, medical students, and patients to view immersive, interactive holograms of the human body captured through medical scans in their real-world environment. Visualizing the renderings through the app could assist in surgical planning and medical education, or help patients visualize procedures.
HCPLive
MARCH 6, 2024
FDA issued a Complete Response Letter to Vanda Pharmaceuticals stating tasimelteon for treating insomnia cannot be approved in its current form due to identified deficiencies.
Science Daily - Heart Disease
MARCH 7, 2024
Adults who had amblyopia ('lazy eye') in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study.
Med Page Today
MARCH 8, 2024
(MedPage Today) -- Somehow, people with persistent amblyopia (also known as "lazy eye") from childhood had a higher risk of cardiometabolic disorders in adulthood, an observational cohort study showed. Within the U.K. Biobank, people over 40 years.
DAIC
MARCH 6, 2024
Getty Images milla1cf Wed, 03/06/2024 - 18:45 March 6, 2024 — Ensight-AI , a Yale start-up and leader in AI -based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Ensight-AI is leveraging the newly launched U.S.
HCPLive
MARCH 5, 2024
In time for daylight saving time starting on March 10, sleep experts weigh in on the harms of the daylight saving transition, such as increased risks for cardiovascular events, car accidents, and mortality.
Science Daily - Heart Disease
MARCH 5, 2024
Coronary artery calcium scoring with CT can identify symptomatic patients with a very low risk of heart attacks or strokes. Researchers said the findings may one day help some patients with stable chest pain avoid invasive coronary angiography.
Expert insights. Personalized for you.
141 
Let's personalize your content